Synex Synthetics BV 

Trusted tailor-made research every step of the way

At Synex Synthetics, we are dedicated to bringing our customers the very best in custom synthesis, analysis and rare chemical sourcing. Offering a wide range of contract research and development services, we aim to provide our customers with unparalleled support and excellent value for money.

As a privately-owned custom research organisation, we adopt a personalised approach, ideal for all proposals from small, low-budget projects to larger scale process development.

As well as enforcing a strict confidentiality policy, we guarantee that any IP generated in the course of a research project is granted exclusively to the client. 

With newly built, ultramodern facilities in Maastricht, The Netherlands, Synex Synthetics is truly at the heart of European chemistry. 

Synex Synthetics also specialises in sourcing rare and hard-to-find chemicals, from research to commercial scale.

With competitive pricing and our global network of suppliers and collaborators, we can always provide our customers with an appropriate solution to their needs.

With years of combined expertise and contacts with academic institutions and other partner organisations, our experienced team can access specialist knowledge and information quickly and efficiently.

Our cost-efficient analytical services include purity screening, structure identification and structure elucidation.

With our state-of-the-art analytical equipment, our experienced, impartial chemists can also perform complex separations and isolations, using an advanced automated flash chromatography system.

Synex Synthetics’ analytical laboratory includes the following equipment:

  • Thermo Scientific Dionex UltiMate 3000 UHPLC
  • Thermo Scientific TSQ Access LC/MS/MS
  • Agilent Technologies 5975C Inert MSD GC/MS
  • NMR (various models from 300 to 600 MHz)
  • Bruker FTIR
  • Buchi Reveleris® X2 Preparative Flash Chromatography System
  • Stuart melting-point apparatus
  • Polarimeter

In addition to our analytical support, all products supplied by us are subjected to our meticulous QC procedure before shipment and issued with a certificate of analysis.

Synex Synthetics’ state-of-the-art laboratory opened in 2017, after an extensive redesign of our premises.

Our in-house facilities consist of four modern laboratories, including an analytical laboratory, kilolab and two R&D laboratories.

As well as our analytical equipment, Synex Synthetics’ laboratory has the capacity to deal with a wide range of chemical reactions, with equipment including:

  • Radleys Carousel 6 Plus Reaction Station
  • Various vacuum-jacketed reactors from 250ml to 20L with Huber thermostats (-80°C to +200°C)
  • Buchi R-220 Pro 20L rotary evaporator and multiple bench-top units
  • Microwave and photochemical reactor
  • High-capacity vacuum-filtration system
  • Ultra-low vacuum pumps and vacuum oven

Synex Synthetics BV

Karveelweg 20
6222 NH Maastricht
THE NETHERLANDS
+31432058102
info@synexsynthetics.com

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI